Leuprolide Acetate
CAS 74381-53-6 17 FDA-DMF suppliersPeptide
Overview
Leuprolide acetate is a synthetic nonapeptide analogue of gonadotropin-releasing hormone (GnRH) used in the treatment of hormone-responsive cancers such as prostate cancer and conditions like endometriosis. It acts by temporarily suppressing the production of certain hormones.
API suppliers (15)
Suppliers of Leuprolide Acetate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- CHEMI SPAItaly1 active DMF
- BACHEM INC1 active DMF
- CHEMI SPAItaly1 active DMF
- Takeda Pharmaceutical Company LimitedJapan1 active DMF
- Piramal Pharma LimitedIndia1 active DMF
- BACHEM INC1 active DMF
- CHEMI SPAItaly1 active DMF
- Piramal Pharma LimitedIndia1 active DMF
- Takeda Pharmaceutical Company LimitedJapan1 active DMF
- Piramal Pharma LimitedIndia1 active DMF
- BACHEM AMERICAS INC
- SPECGX LLCUnited States
- Genzyme CorporationUnited States
- Taro Pharmaceutical Industries Ltd.Israel
- CHINESE PEPTIDE COChina
Therapeutic areas
OncologyEndocrinologyGynecology
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.